Palisades Hudson Asset Management, L.P. Bristol Myers Squibb CO Transaction History

Palisades Hudson Asset Management, L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$57.89 - $64.73 $1,389 - $1,553	-24 Reduced 0.66%	3,638 $211,000
Q1 2023 Apr 26, 2023	SELL	$65.71 - $74.53 $2,891 - $3,279	-44 Reduced 1.19%	3,662 $254,000
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $753 - $891	11 Added 0.3%	3,706 $267,000
Q3 2022 Oct 28, 2022	SELL	$0.13 - $76.84 $21 - $12,678	-165 Reduced 4.27%	3,695 $263,000
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $14,378 - $15,836	198 Added 5.41%	3,860 $297,000
Q1 2022 Apr 27, 2022	SELL	$61.48 - $73.72 $43,158 - $51,751	-702 Reduced 16.09%	3,662 $268,000
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $14,987 - $21,779	-323 Reduced 6.89%	4,364 $243,000
Q4 2019 Jan 30, 2020	BUY	$49.21 - $64.19 $15,894 - $20,733	323 Added 7.4%	4,687 $301,000
Q3 2019 Oct 17, 2019	BUY	$42.77 - $50.71 $186,648 - $221,298	4,364 New	4,364 $221,000
Q2 2019 Jul 30, 2019	SELL	$44.62 - $49.34 $194,721 - $215,319	-4,364 Closed	0 $0
Q1 2019 Apr 23, 2019	SELL	$45.12 - $53.8 $31,584 - $37,660	-700 Reduced 13.82%	4,364 $208,000
Q3 2018 Nov 08, 2018	SELL	$55.19 - $62.25 $4,635 - $5,229	-84 Reduced 1.63%	5,064 $314,000
Q4 2017 Feb 09, 2018	SELL	$59.94 - $65.35 $10,549 - $11,501	-176 Reduced 3.31%	5,148 $315,000
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $294,044 - $339,351	5,324	5,324 $339,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Palisades Hudson Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Palisades Hudson Asset Management, L.P. with notifications on news.